Cargando…

De Novo Donor-Specific HLA Antibody Development and Peripheral CD4(+)CD25(high) Cells in Kidney Transplant Recipients: A Place for Interaction?

The aim of this study was to determine whether the abundance of regulatory T cells (Tregs) (CD4(+)CD25(high)) affects the de novo development of anti-HLA donor-specific antibodies (DSAs) in kidney transplant recipients (KTRs). Methods. Unsensitized (PRA ≤ 10%, no DSA) adult primary KTRs who received...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alberu, Josefina, Vargas-Rojas, Maria Inés, Morales-Buenrostro, Luis E., Crispin, Jose C., Rodríguez-Romo, Roxana, Uribe-Uribe, Norma O., Carrasco, Gabriel, Gómez-Martín, Diana, Alcocer-Varela, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432543/ https://www.ncbi.nlm.nih.gov/pubmed/22970343 http://dx.doi.org/10.1155/2012/302539

Ejemplares similares

Renal transplant recipient with advanced HIV infection: graft and peripheral cell population analysis
por: Bostock, Ian C, et al.
Publicado: (2013)

Fever, Haematuria, and Acute Graft Dysfunction in Renal Transplant Recipients Secondary to Adenovirus Infection: Two Case Reports
por: Ramírez, J., et al.
Publicado: (2013)

The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients
por: O'Leary, Jacqueline G., et al.
Publicado: (2016)

Microsporidia Infection in a Mexican Kidney Transplant Recipient
por: Hernández-Rodríguez, Oscar Xavier, et al.
Publicado: (2012)

C1Q Assay Results in Complement-Dependent Cytotoxicity Crossmatch Negative Renal Transplant Candidates with Donor-Specific Antibodies: High Specificity but Low Sensitivity When Predicting Flow Crossmatch
por: Arreola-Guerra, José M., et al.
Publicado: (2016)

Peripheral Regulatory Cells Immunophenotyping in Kidney Transplant Recipients with Different Clinical Profiles: A Cross-Sectional Study
por: Furuzawa-Carballeda, Janette, et al.
Publicado: (2012)

Nonimmunologic Donor-Recipient Pairing, HLA Matching, and Graft Loss in Deceased Donor Kidney Transplantation
por: Vinson, Amanda Jean, et al.
Publicado: (2018)

De Novo Cytomegalovirus Colitis in a Donor-Seronegative/Recipient-Seronegative Kidney Transplant Recipient
por: Sulaiman, Zoheb I, et al.
Publicado: (2023)

Characterization of donor and recipient CD8+ tissue-resident memory T cells in transplant nephrectomies
por: de Leur, Kitty, et al.
Publicado: (2019)

Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients
por: Lee, Hyeyoung, et al.
Publicado: (2018)

Combined Analysis of HLA Class II Eplet Mismatch and Tacrolimus Levels for the Prediction of De Novo Donor Specific Antibody Development in Kidney Transplant Recipients
por: Lee, Hyeyoung, et al.
Publicado: (2022)

HLA‐EPI: A new EPIsode in exploring donor/recipient epitopic compatibilities
por: Geffard, Estelle, et al.
Publicado: (2021)

The natural history of de novo donor-specific HLA antibodies after kidney transplantation
por: López del Moral, Covadonga, et al.
Publicado: (2022)

De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients
por: Cioni, Michela, et al.
Publicado: (2017)

Association of intraindividual tacrolimus variability with de novo donor-specific HLA antibody development and allograft rejection in pediatric kidney transplant recipients with low immunological risk
por: Baghai Arassi, Maral, et al.
Publicado: (2022)

Association between SARS-CoV-2 infection and de novo HLA donor specific antibody production in lung transplant recipients: Single-center study
por: Shah, Sadia Z., et al.
Publicado: (2022)

Impact of Resolved Preformed, Persistent Preformed, and De Novo Anti-HLA Donor-Specific Antibodies in Kidney Transplant Recipients on Long-Term Renal Graft Outcomes
por: Gniewkiewicz, Michal, et al.
Publicado: (2023)

Influence of Donors’ and Recipients’ HLA Typing on Renal Function Immediately After Kidney Transplantation
por: Rostami, Zohreh, et al.
Publicado: (2013)

Predicting Humoral Alloimmunity from Differences in Donor and Recipient HLA Surface Electrostatic Potential
por: Mallon, Dermot H., et al.
Publicado: (2018)

Donor–Recipient Non-HLA Variants, Mismatches and Renal Allograft Outcomes: Evolving Paradigms
por: Jethwani, Priyanka, et al.
Publicado: (2022)

Frequencies of CD33+CD11b+HLA-DR–CD14–CD66b+ and CD33+CD11b+HLA-DR–CD14+CD66b– Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19
por: Alberca, Ricardo Wesley, et al.
Publicado: (2020)

Association Between Severe SARS-CoV-2 Infection and De Novo HLA Donor Specific Antibody Production in Lung Transplant Recipients: Single-center study
por: Shah, Sadia, et al.
Publicado: (2023)

Donor HLA−DR Drives the Development of De Novo Autoimmunity Following Lung and Heart Transplantation
por: Jankowska−Gan, Ewa, et al.
Publicado: (2020)

X-ray irradiation selectively kills thymocytes of different stages and impairs the maturation of donor-derived CD4(+)CD8(+) thymocytes in recipient thymus
por: Li, Jinbo, et al.
Publicado: (2012)

B cell depletion with anti-CD20 mAb exacerbates anti-donor CD4(+) T cell responses in highly sensitized transplant recipients
por: Tanaka, Asuka, et al.
Publicado: (2021)

Effect of Preformed or De Novo Anti-HLA Antibodies on Function and Graft Survival in Kidney Transplant Recipients
por: de Sousa, Marcos Vinicius, et al.
Publicado: (2018)

Natural soluble human leukocyte antigen class I in donor serum neutralizes donor-specific HLA alloantibodies in recipient serum
por: Won, Dong Il, et al.
Publicado: (2020)

Single fixed low-dose rituximab as induction therapy suppresses de novo donor-specific anti-HLA antibody production in ABO compatible living kidney transplant recipients
por: Tomita, Yusuke, et al.
Publicado: (2019)

Expression of HLA-I, CD8, and CD4 and Their Clinical Significance in Cervical Cancer
por: Fan, Jiang Tao, et al.
Publicado: (2011)

Characteristics and Clinical Significance of De Novo Donor-Specific Anti-HLA Antibodies after Kidney Transplantation
por: Jung, Hee-Yeon, et al.
Publicado: (2018)

Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation
por: Meneghini, Maria, et al.
Publicado: (2021)

HLA-DR polymorphism affects the interaction with CD4
Publicado: (1995)

Predicting HLA CD4 Immunogenicity in Human Populations
por: Dhanda, Sandeep Kumar, et al.
Publicado: (2018)

Donor CD4 T Cell Diversity Determines Virus Reactivation in Patients After HLA-Matched Allogeneic Stem Cell Transplantation
por: Ritter, J, et al.
Publicado: (2015)

Occurrence of De novo Donor-Specific Antibodies After COVID-19 in Kidney Transplant Recipients Is Low Despite Immunosuppression Modulation
por: Masset, Christophe, et al.
Publicado: (2022)

The Presence of HLA-E-Restricted, CMV-Specific CD8(+) T Cells in the Blood of Lung Transplant Recipients Correlates with Chronic Allograft Rejection
por: Sullivan, Lucy C., et al.
Publicado: (2015)

Many de novo donor‐specific antibodies recognize β(2)‐microglobulin‐free, but not intact HLA heterodimers
por: Michel, K., et al.
Publicado: (2016)

Importance and What to Watch Out for De Novo Donor Specific Anti-HLA Antibodies after Kidney Transplantation
por: Yang, Chul Woo
Publicado: (2018)

Donor-Derived Regulatory Dendritic Cell Infusion Maintains Donor-Reactive CD4(+)CTLA4(hi) T Cells in Non-Human Primate Renal Allograft Recipients Treated with CD28 Co-Stimulation Blockade
por: Ezzelarab, Mohamed B., et al.
Publicado: (2018)

Recipient HLA-G +3142 CC Genotype and Concentrations of Soluble HLA-G Impact on Occurrence of CMV Infection after Living-Donor Kidney Transplantation
por: Guberina, Hana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_965e23cb1rk25ln42s0l353p3p